MedTrace Logo

AKI Prevention and Early Intervention in Patients Undergoing VAD Placement

NCT03236831 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2019-10-10

No results posted yet for this study

Summary

The investigators are doing this research to find out if more careful assessment and elimination of potential risk factors of acute kidney injury (AKI) during the subject's perioperative period will reduce their chance of kidney damage and kidney damage related problems.

Conditions

  • Kidney Injury

Interventions

OTHER

Clinical Recommendations

The investigators will provide clinical recommendations to the subject's primary care provider. These will be in regards to the following: 1. Avoidance of potentially nephrotoxic medications. 2. Optimizing volume status (avoidance of volume overload or depletion) 3. Optimizing electrolytes and acid-base status 4. Minimizing IV contrast exposure when appropriate 5. Treating severe anemia 6. Optimization of hemodynamics (Mean arterial BP\>65mmHg)

Sponsors & Collaborators

Principal Investigators

  • Qi Qian, M.D. · Mayo Clinic

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-11
Primary Completion
2019-02-17
Completion
2019-02-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03236831 on ClinicalTrials.gov